Skip to content

Avant Diagnostics, Inc

CIK 0001451929

← back to feed
Revenue (TTM)
$255.95K
+116.8% YoY Q1 Feb 2019
Net Income (TTM)
−$1.99M
+75.3% YoY Q1 Feb 2019
EPS Diluted (TTM)
—
Q1 Feb 2019
Gross Margin
89.2%
Q1 Feb 2019
Operating Margin
-793.5%
Q1 Feb 2019
Net Margin
-777.6%
Q1 Feb 2019
Free Cash Flow (TTM)
—
Q1 Feb 2019
Cash
$62.25K
Q1 Feb 2019
Total Debt
—
Q1 Feb 2019
Shares Outstanding
336.96M sh
Q1 Feb 2019

Revenue & Net Income

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings